Search

Author/Creator Chiappori, Alberto A

1. First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors. Issue 10 (27th October 2022)

Authors:
Hamid, Omid; Chiappori, Alberto A; Thompson, John A; Doi, Toshihiko; Hu-Lieskovan, Siwen; Eskens, Ferry A L M; Ros, Willeke; Diab, Adi; Spano, Jean-Philippe; Rizvi, Naiyer A; Wasser, Jeffrey S; Angevin, Eric; Ott, Patrick A; Forgie, Alison; Yang, Wenjing; Guo, Cen; Chou, Jeffrey; El-Khoueiry, Ant...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 10(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancers. Issue 9 (13th September 2016)

Authors:
Kubal, Timothy; Letson, Doug G; Chiappori, Alberto A; Springett, Gregory M; Shimkhada, Riti; Tamondong Lachica, Diana; Peabody, John W
Journal:
BMJ open
Issue:
Volume 6:Issue 9(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search